Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $48 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland has reiterated a Buy rating for Select Medical Holdings (NYSE:SEM) and maintained a price target of $48.
September 06, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bill Sutherland has reiterated a Buy rating for Select Medical Holdings and maintained a price target of $48, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $48 price target by a reputable analyst suggests a positive outlook for Select Medical Holdings. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100